122 related articles for article (PubMed ID: 9044533)
1. Conditional power calculations for early acceptance of H0 embedded in sequential tests.
Betensky RA
Stat Med; 1997 Feb; 16(4):465-77. PubMed ID: 9044533
[TBL] [Abstract][Full Text] [Related]
2. Early stopping to accept H(o) based on conditional power: approximations and comparisons.
Betensky RA
Biometrics; 1997 Sep; 53(3):794-806. PubMed ID: 9290216
[TBL] [Abstract][Full Text] [Related]
3. An additive boundary for group sequential designs with connection to conditional error.
Xi D; Gallo P
Stat Med; 2019 Oct; 38(23):4656-4669. PubMed ID: 31338847
[TBL] [Abstract][Full Text] [Related]
4. A general formulation for a one-sided group sequential design.
Moser BK; George SL
Clin Trials; 2005; 2(6):519-28. PubMed ID: 16422312
[TBL] [Abstract][Full Text] [Related]
5. Multi-arm group sequential designs with a simultaneous stopping rule.
Urach S; Posch M
Stat Med; 2016 Dec; 35(30):5536-5550. PubMed ID: 27550822
[TBL] [Abstract][Full Text] [Related]
6. Symmetric group sequential test designs.
Emerson SS; Fleming TR
Biometrics; 1989 Sep; 45(3):905-23. PubMed ID: 2675998
[TBL] [Abstract][Full Text] [Related]
7. Alternatives to the standard Fleming, Harrington, and O'Brien futility boundary.
Anderson JR; High R
Clin Trials; 2011 Jun; 8(3):270-6. PubMed ID: 21441286
[TBL] [Abstract][Full Text] [Related]
8. Design and analysis of group sequential logrank tests in maximum duration versus information trials.
Kim K; Boucher H; Tsiatis AA
Biometrics; 1995 Sep; 51(3):988-1000. PubMed ID: 7548714
[TBL] [Abstract][Full Text] [Related]
9. Group sequential design for comparative diagnostic accuracy studies.
Mazumdar M; Liu A
Stat Med; 2003 Mar; 22(5):727-39. PubMed ID: 12587102
[TBL] [Abstract][Full Text] [Related]
10. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
Lewis RJ; Lipsky AM; Berry DA
Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
[TBL] [Abstract][Full Text] [Related]
11. Group sequential designs for cure rate models with early stopping in favour of the null hypothesis.
Patricia Bernardo MV; Ibrahim JG
Stat Med; 2000 Nov; 19(22):3023-35. PubMed ID: 11113940
[TBL] [Abstract][Full Text] [Related]
12. Optimality criteria for futility stopping boundaries for group sequential designs with a continuous endpoint.
Li X; Herrmann C; Rauch G
BMC Med Res Methodol; 2020 Nov; 20(1):274. PubMed ID: 33153438
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous sequential monitoring of efficacy and safety led to masking of effects.
van Eekelen R; de Hoop E; van der Tweel I
J Clin Epidemiol; 2016 Aug; 76():155-65. PubMed ID: 26944293
[TBL] [Abstract][Full Text] [Related]
14. Testing a primary and a secondary endpoint in a group sequential design.
Tamhane AC; Mehta CR; Liu L
Biometrics; 2010 Dec; 66(4):1174-84. PubMed ID: 20337631
[TBL] [Abstract][Full Text] [Related]
15. Sequential analysis of matched dichotomous data from prospective case-control studies.
Van der Tweel I; van Noord PA
Stat Med; 2000 Dec; 19(24):3449-64. PubMed ID: 11122507
[TBL] [Abstract][Full Text] [Related]
16. Sequential methods and group sequential designs for comparative clinical trials.
Sébille V; Bellissant E
Fundam Clin Pharmacol; 2003 Oct; 17(5):505-16. PubMed ID: 14703713
[TBL] [Abstract][Full Text] [Related]
17. A decision rule for sequential monitoring of clinical trials with a primary and supportive outcome.
Zhao Y; Grambsch PM; Neaton JD
Clin Trials; 2007; 4(2):140-53. PubMed ID: 17456513
[TBL] [Abstract][Full Text] [Related]
18. Multiple imputation for early stopping of a complex clinical trial.
Betensky RA
Biometrics; 1998 Mar; 54(1):229-42. PubMed ID: 9544518
[TBL] [Abstract][Full Text] [Related]
19. Statistical rules for safety monitoring in clinical trials.
Martens MJ; Logan BR
Clin Trials; 2024 Apr; 21(2):152-161. PubMed ID: 37877375
[TBL] [Abstract][Full Text] [Related]
20. Flexible implementations of group sequential stopping rules using constrained boundaries.
Burington BE; Emerson SS
Biometrics; 2003 Dec; 59(4):770-7. PubMed ID: 14969454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
